Semaglutide vs Liraglutide — Research Comparison
⚠ Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not for human consumption, therapeutic use, or clinical application. Buyers must comply with all applicable local laws and regulations.
A research reference comparing Semaglutide and Liraglutide — GLP-1 receptor agonist research comparison — older vs newer generation. This comparison is for scientific research reference only.
Side-by-Side Comparison
| Property | Semaglutide | Liraglutide |
| CAS Number | 910463-68-6 | 204656-20-2 |
| Category | GLP-1 Agonist | GLP-1 Agonist |
| Research Use | GLP-1 receptor agonism and metabolic research | GLP-1 receptor and metabolic pathway research |
| Purity (Aarise) | 98%+ HPLC | 98%+ HPLC |
| Form | Lyophilised powder | Lyophilised powder |
Research Applications
Semaglutide is primarily studied for GLP-1 receptor agonism and metabolic research. Liraglutide is studied for GLP-1 receptor and metabolic pathway research. Researchers choose between these compounds based on their specific experimental model and endpoints.
Source Both Compounds from Aarise Healthcare
Aarise Healthcare supplies both Semaglutide and Liraglutide at 98%+ purity from our WHO-GMP certified facility. Order both compounds together for consistent quality across your comparative research programme.
Request pricing for Semaglutide and Liraglutide: Contact our research supply team with your quantity requirements. We respond within 24 hours.
